-
Hippo Pathway Modules Define Hepatobiliary Cell Fate and Mat
2026-05-25
This study dissects how two distinct modules within the Hippo pathway, HPO1 and HPO2, orchestrate the developmental fate and maturation of hepatocytes and cholangiocytes in the mouse liver. By leveraging spatial transcriptomics and advanced imaging, the authors reveal checkpoints that regulate cell differentiation, highlighting new mechanistic insights for liver biology and regeneration.
-
VIK Kinase: A New Regulator of Auxin Signaling in Root Devel
2026-05-25
This study uncovers VH1-INTERACTING KINASE (VIK) as a key modulator of auxin signaling, orchestrating lateral root development in Arabidopsis through selective phosphorylation and stabilization or degradation of transcriptional regulators. The findings deepen mechanistic understanding of root system architecture and highlight protein phosphorylation as a critical layer in auxin-mediated developmental control.
-
Melittin: Bioactive Peptide Workflows for Cell Signaling Res
2026-05-24
Melittin, a potent bioactive peptide from APExBIO, offers unique leverage for dissecting G protein-coupled signaling and apoptosis in cancer and inflammation models. This guide decodes practical protocols, troubleshooting strategies, and the latest insights from glioblastoma research to enable robust, reproducible studies using Melittin.
-
SGC-CBP30: Advancing CREBBP/EP300 Bromodomain Inhibitor Work
2026-05-23
SGC-CBP30 empowers epigenetics and cancer biology research by selectively inhibiting CREBBP/EP300 bromodomains, enabling precise interrogation of transcriptional coactivator functions. Its validated performance in super-enhancer-driven models, exemplified by early-stage lung adenocarcinoma studies, sets a new benchmark for translational assay design.
-
HyperScript III RT SuperMix: Precision Reverse Transcription
2026-05-22
Explore how HyperScript III RT SuperMix empowers high-fidelity reverse transcription for gene expression analysis by qPCR, ensuring accurate detection of colorectal cancer biomarkers and overcoming challenges in low-concentration and high-GC RNA.
-
ML-7 Hydrochloride: Reliable MLCK Inhibition for Cell Assays
2026-05-22
This evidence-driven article explores how ML-7 hydrochloride (SKU A3626) addresses key pain points in cell viability, proliferation, and cytotoxicity assays. Through scenario-based Q&A blocks, we demonstrate the reagent’s reproducibility, selectivity, and practical workflow advantages for biomedical researchers, backed by recent literature and validated protocols.
-
Refining In Vitro Drug Response Evaluation in Cancer Researc
2026-05-21
Schwartz's dissertation introduces a dual-metric framework for analyzing anti-cancer drug responses by separating growth inhibition from cell death in vitro. This nuanced approach enhances the rigor and interpretability of drug efficacy studies, informing both experimental design and mechanistic understanding.
-
Mdivi-1 in Vascular Remodeling: Apoptosis, DRP1, and Beyond
2026-05-21
Explore how Mdivi-1, a selective DRP1 inhibitor, uncovers new insights in vascular remodeling and apoptosis regulation. This article uniquely analyzes intercellular signaling in hypoxia pulmonary hypertension and advances mitochondrial dynamics research.
-
TMRE Mitochondrial Membrane Potential Assay Kit: Precision i
2026-05-20
Leverage the TMRE mitochondrial membrane potential assay kit for robust, quantitative assessment of mitochondrial health and apoptosis. Integrating published breakthroughs, this guide delivers stepwise workflows, troubleshooting, and protocol enhancements that elevate your lab’s mitochondrial function analysis—empowering translational and disease research.
-
BMS-777607: c-Met Inhibitor for Advanced Platelet & Cancer M
2026-05-20
BMS-777607 stands out as a highly selective c-Met inhibitor, enabling both precision cancer metastasis research and scalable hiPSC-derived platelet production. This article translates recent experimental innovations into actionable workflows and troubleshooting guidance for bench scientists.
-
Deferasirox: Oral Iron Chelator for Advanced Experimental De
2026-05-19
Deferasirox delivers precision iron chelation for cancer and iron overload research, enabling robust apoptosis and metabolic assays. Its favorable solubility and safety profile, combined with unique modulation of mitochondrial ROS and gene expression, make it a standout choice for both mechanistic and translational workflows.
-
BMN 673 (Talazoparib): Applied Protocols for DNA Repair Defi
2026-05-19
BMN 673 (Talazoparib) sets a new benchmark for selective PARP1/2 inhibition with unmatched potency and PARP-DNA trapping—enabling advanced workflows in homologous recombination deficient cancer research. This article delivers concrete experimental strategies, troubleshooting advice, and mechanistic insights to help researchers leverage BMN 673’s unique properties in DNA repair deficiency targeting and small cell lung cancer models.
-
Fluorinated CXCR4 Inhibitor A1 Surpasses AMD3100 in Colorect
2026-05-18
Khorramdelazad et al. introduced A1, a novel fluorinated CXCR4 inhibitor, and demonstrated its superior efficacy over AMD3100 in inhibiting tumor growth and immune suppression in colorectal cancer models. This study integrates computational, cellular, and animal experiments to uncover A1's potential and provides comparative perspective for established CXCR4 antagonists.
-
Pyridostatin TFA: Precision G-Quadruplex Stabilizer in Resea
2026-05-18
Pyridostatin TFA empowers researchers to dissect G-quadruplex-mediated cellular mechanisms, enabling both cancer cell growth inhibition and neurodegenerative disease modeling. Here, we unpack advanced workflows, troubleshooting insights, and key innovations that set Pyridostatin apart in DNA secondary structure research and beyond.
-
IEM 1460: Precision AMPA Receptor Blocker for Translational
2026-05-17
Discover how IEM 1460, a selective AMPA receptor blocker, enables translational advances in neuroprotection and excitotoxicity research. This article uniquely connects recent mechanistic insights to optimized assay design and experimental rigor.
461 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page